A vial and syringe are seen in front of Merck logo in this illustration taken March 26, 2025. REUTERS/Dado Ruvic/Illustration© Thomson Reuters ...

Merck's oral cholesterol pill succeeded in two late-stage studies, marking a win for the drugmaker as it focuses on the development of growth drivers beyond its cancer drugs and vaccines.

U.S. drugmaker Merck said on Tuesday it is investing $1 billion in a new Delaware plant to expand domestic production as it prepares to deal with President Donald Trump's tariffs.

Germany’s Merck MRK -0.53% KGaA shares dropped after the company slashed its full-year outlook on the back of uncertainty around tariffs and foreign-exchange headwinds.

The new facility will produce biologic drugs and Keytruda, becoming Merck’s first in-house US site to make the blockbuster cancer treatment, the company said.

Merck & Co. undefined said Tuesday it plans to begin a sequenced Phase III program next year for MK-0859, anacetrapib -- designed to raise good cholesterol ...

Merck KGaA, the German science and technology group, trimmed its profit forecast, citing a weakening US dollar and uncertainty around global tariffs. The stock tumbled.

The simplicity of Merck's monoclonal antibody for RSV in infants could be a plus in its competition with AstraZeneca's existing treatment.

Shares of Merck fell 9% after the company reported that in the second quarter, it saw a decrease in shipments of its HPV vaccine Gardasil in China.

RIVERSIDE, Pa. — More than 150 people are losing their jobs this summer in Northumberland County. According to a PA warning notice, Merck in Riverside, one of the county's largest employers, is ...

Merck and a woman suing the drugmaker agreed to halt a trial over alleged injuries from the drugmaker's human papillomavirus vaccine in a case with ties to U.S. Department of Health and Human ...